DRKS00032573尚未招募不适用
Development of a marker panel for the individualized bDMARD therapy of psoriatic arthritis (Integrate-PsA) - Integrate-PsA
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Diagnosis of active PsA (psoriatic arthritis)
- •- No MDA status (minimal disease activity) after at least 3 months of MTX (methotrexate) treatment
- •- Clinical indication for treatment escalation from MTX to a b-DMARD (biologic disease-modifying antirheumatic drug)
- •- Switch to one of the following three biologic classes: TNFi (tumour necrosis factor inhibitor), IL17i (Interleukin 17 Inhibitor) and IL23i (Interleukin 23 Inhibitor)
排除标准
- •- Non-response or intolerance to MTX (methotrexate)
研究者
相似试验
招募中
不适用
Developement of Diagnostic and monitoring marker for allergic disease and pulmonary diseaseDiseases of th respiratory systemKCT0000112Wonkwang University Hospital500
招募中
不适用
The missing link between daily life and the therapist's office.Major depressive disorder (MDD)DepressieNL-OMON29463niversity Medical Center Groningen, Department of Psychiatry100
尚未招募
1 期
Development for certificated medical markers using safe pigments in the human bodyDiseases for which extractions are performed, jaw deformities, jaw bone cysts, jaw bone tumors, oralJPRN-jRCTs032230507MARUOKA Yutaka5
已完成
不适用
Development of a Digital Tool for the Individualization of Speech Therapy Care for Premature NewbornsPremature BirthNCT05992181Centre Hospitalier Sud Francilien30
已完成
不适用
Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV PatientsAcquired Immunodeficiency Syndrome VirusHepatitis, Viral, Non-A, Non-B, Parenterally-TransmittedHepatocellular CarcinomaNCT02113865Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal45